Key statistics
As of last trade, Carisma Therapeutics Inc (W2J:FRA) traded at 0.8355, 16.93% above the 52 week low of 0.7145 set on Aug 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.829 |
---|---|
High | 0.8355 |
Low | 0.829 |
Bid | 0.842 |
Offer | 0.875 |
Previous close | 0.849 |
Average volume | 404.11 |
---|---|
Shares outstanding | 41.54m |
Free float | 28.79m |
P/E (TTM) | -- |
Market cap | 38.64m USD |
EPS (TTM) | -1.78 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 14:29 BST.
More ▼
Press releases
- Carisma Therapeutics Announces Upcoming Presentations at SITC 2024
- Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
- Carisma Therapeutics to Present at Upcoming Conferences
- Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024
- Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board
More ▼